Friday, 27 Mar 2020

You are here

The RheumNow Week in Review - 16 February 2018

Dr. Jack Cush reviews highlights, news and recent research published this week on RheumNow.com. This week's report includes news on social media, new rituximab indications, steroid complications, DECT in Gout, T2T in gout, Dementia and rheumatology numbers.

  1. Cambridge study shows that hand thermoregulation is more dependant on muscle mass and not fat - this may be why more women than men bothered by "cold hands" https://t.co/j5zCt3ntW8
  2. Pharmacovigilance using Twitter? A UK study compared glucocorticoid AE on Twitter vs UK MHRA regulatory system; in 3 yrs, Twitter Identified 20,210 Steroid AE, but only 3022 via MHRA. Twitter AE “common but not serious”, most being insomnia and weight gain https://buff.ly/2o8LW9F
  3. FDA grants priority review for Genentechs Rituxan for use in pemphigus vulgaris https://t.co/e6uKQOf55f
  4. 240,000 Canadian COPD patients, >55 yrs; those on inhaled corticosteroids (>4 yrs, >1gm) had 10% higher rate of fractures (men and women) https://t.co/N4rJwrfohY
  5. Systematic review of DECT Scanning in Gout included 32 articles & 1502 pts. DECT takes little time and has low radiation exposure but limited availability. It showed Sensitivity & Specificity > 80%. Dx performance was better than Xray, CT, equal to US https://t.co/GkbSKNP7D2   
  6. Although epratuzumab (anti-CD22 MAb) failed in SLE in two phase III clinical trials, subanalyses show that pts w/ secondary Sjogrens who were SSA positive (7.1% of 1584 enrolled) where more likely to have a BICLA response and decreases in B cells and IgM. https://t.co/n6Woy8rTka
  7. T2T Improves Primary Care Gout Management  
  8. DMARDs Lower Dementia Risk in Rheumatoid Arthritis  40% reduction; 50% w/ MTX 
  9. NHANES Survey Shows OA Rising and RA Declining 

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

RheumNow Podcast – New World Order (3.27.20)

Dr. Jack Cush reviews the news and COVID developments from this past week.

Global Rheumatology Alliance Registry Will Study COVID-19

In the midst of a global pandemic of the 2019 Novel coronavirus acute respiratory disease (COVID-19), a small handful of Rheumatologists gathered on social media to collectively grapple with the impact of this virus on vulnerable populations with rheumatic disease.

RheumNow Podcast- COVID Siege (3.20.20)

Dr. Jack Cush reviews the past week of COVID-19 news and advances.

COVID-19 Rheumatology News

With the COVID-19 pandemic dynamically changing, we have provided several news items germane to the Rheumatologist.

The COVID-19 Global Rheumatology Registry

As the highly virulent SARS-CoV-2 spreads over the world, uncertainty and fear for our patients with rheumatic diseases mount.  

As of March 17, 2020 over 183,000* cases of Coronavirus disease 2019 (COVID-19) have been recorded, with the majority in China and Europe, but that may be the tip of the iceberg. Many more cases likely exist that are undetected due to shortages in testing supplies.